Integrated BioPharma, Inc.

INBP

US45811V1052

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 02:39:01 2024-07-15 pm EDT			5-day change	1st Jan Change
0.2 ^USD	0.00%		0.00%	-18.43%

May. 10	Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
Feb. 12	Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

INTEGRATED BIOPHARMA INC : Financial Statements and Exhibits (form 8-K)

June 21, 2022 at 05:16 pm EDT

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit relating to Item 5.07 shall be deemed to be furnished, and not filed:



99.1     Press Release Dated June 21, 2022
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                      -1-

--------------------------------------------------------------------------------

Latest news about Integrated BioPharma, Inc.

Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 10	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 12	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 09	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-09-15	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-15	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-11	CI
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President	23-03-21	CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement	23-03-17	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-10	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-10	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-13	CI
Integrated Biopharma, Inc. Announces Change in Directors	22-06-21	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q1 Revenue $15.6M	22-05-12	MT
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-12	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q4 Revenue $14.6M	22-02-10	MT
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-10	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $12.8M	21-11-10	MT
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-10	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	21-09-02	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-13	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-02-12	CI
Integrated BioPharma : Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $15.2M	20-11-12	MT
Integrated Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	20-11-12	CI
Integrated Biopharma, Inc. Appoints Eric Friedman as Director and to the Audit Committee of the Board of Directors	20-11-09	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2020	20-09-23	CI

Chart Integrated BioPharma, Inc.

Duration

Period

More charts

Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.

Sector

Pharmaceuticals

Calendar

2024-09-11 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INTEGRATED BIOPHARMA, INC.	-18.43%	6.02M
ELI LILLY AND COMPANY	+55.35%	848B
NOVO NORDISK A/S	+31.64%	627B
JOHNSON & JOHNSON	-0.10%	363B
MERCK & CO., INC.	+15.47%	318B
ABBVIE INC.	+13.10%	299B
ASTRAZENECA PLC	+15.51%	243B
NOVARTIS AG	+16.72%	225B
AMGEN INC.	+16.54%	179B
PFIZER, INC.	+4.31%	167B